Detalhe da pesquisa
1.
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.
N Engl J Med
; 384(25): 2394-2405, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34081848
2.
Addressing disparities in cancer clinical trials: a roadmap to more equitable accrual.
Front Health Serv
; 4: 1254294, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38523649
3.
Multidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinoma.
J Cancer Res Clin Oncol
; 149(15): 14125-14136, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37552307
4.
Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines.
J Clin Oncol
; 24(30): 4914-21, 2006 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-17050875
5.
A case report of invasive ductal adenocarcinoma identified in a lymphatic channel: a staging controversy.
Cancer Control
; 10(5): 411-3, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-14581896